According to a study recently presented at the 2016 San Antonio Breast Symposium, BRCA1 and BRCA2 genetic status does not predict survival rates in young women with breast cancer. “There is no significant difference in survival between BRCA gene carriers and non-carriers amongst all young breast cancer patients,” reported Diana Eccles, MD, of the University of Southampton, United Kingdom. The study did find a difference in survival rates between women who have a triple negative breast tumor with and without a BRCA 1 or BRCA2 gene mutation. Women who have a triple negative breast tumor and a BRCA gene mutation had a better survival rate (11%) than those women who had a triple negative breast tumor and no BRCA gene mutation. The average age for the women in the study were 36 years old.
To learn more about the study please click on this link. http://bit.ly/2gmaMSc